Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00429338 · ClinicalTrials.gov registry record · NA
3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate
A NA study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00429338: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT00429338 is a NA study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00429338, a NA study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the feasibility of 3T magnetic resonance spectroscopic imaging (MRSI) of the prostate in improving the spectral resolution, using a perfluorocarbon compound (PFC)-filled endorectal coil. Specific Aim 1: To compare the spectral quality, measured in Hz (linewidth), of 3T MRSI performed with an air-filled endorectal coil (AIR-MRSI) and a PFC-filled endorectal coil (PFC-MRSI). Specific Aim 2: To compare the quality of spectra of PFC-MRSI by grading the overall quality of MRSI data of each patient subjectively as being "excellent," "good," "fair," "poor," and "non-diagnostic," based on the status of subjective spectral resolution of Cho, Cr and Po peaks, signal to noise ratio (SNR), baseline distortion, and fat contamination.
Interventions
- PROCEDURE AIR-MRSI
- PROCEDURE PFC-MRSI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2007-01 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00429338
The ClinicalTrials.gov registry entry for NCT00429338 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AIR-MRSI is the first listed.
NCT00429338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00429338 about?
NCT00429338 is a clinical study titled "3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate". The objective of this study is to evaluate the feasibility of 3T magnetic resonance spectroscopic imaging (MRSI) of the prostate in improving the spectral resolution, using a perfluorocarbon compound (PFC)-filled endorectal coil. Specific Aim 1: To compare the spectral quality, measured in Hz (line...
What is the current status of trial NCT00429338?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2007-01. Estimated completion is 2013-10.
What interventions are being tested in trial NCT00429338?
The interventions under investigation include: AIR-MRSI (PROCEDURE), PFC-MRSI (PROCEDURE).
Who is sponsoring clinical trial NCT00429338?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.